The FDA has granted Fast Track designation to a novel therapy for the treatment of moderate-to-severe alopecia areata. For details, read more.   READ MORE

Collaborating Associations

Business Insider Series

Lawrence Eichenfield, MD, reports on major developments in the changing field of pediatric dermatology.

Aesthetics Corner

This case discusses the use of platelet-rich plasma to reverse skin necrosis caused by facial artery occlusion induced by a dermal filler.